Search

everythinglearnresearchcommunity

for

Search:↓

Juvenile alopecia areata is more severe and has a worse prognosis than maturity-onset alopecia areata.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Nail pitting in kids can be harmless or indicate other health issues, so thorough evaluation is crucial.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

DM and AA may share a common cause.

A 13-year-old girl was diagnosed with juvenile lupus, showing only hair loss as a symptom.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Alopecia areata involves immune response and gene changes affecting hair loss.

Effective treatments for severe alopecia areata are still lacking.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Alopecia areata mainly affects young people, often showing as patchy hair loss on the scalp.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

More research is needed to understand alopecia areata severity.